NovelStem International Corp.: Form 10-Q for the period ended Sep 30, 2012
Filed with the SEC on Nov 19, 2012 and accepted by EDGAR at Nov 19, 2012, 16:32 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2012-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2012-07-01 to 2012-09-30 | $96.0k | us-gaap:SalesRevenueNet |
| Revenue | 9 months2012-01-01 to 2012-09-30 | $429.1k | us-gaap:SalesRevenueNet |
| Selling, general and administrative | 3 months2012-07-01 to 2012-09-30 | $639.0k | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2012-01-01 to 2012-09-30 | $1.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2012-07-01 to 2012-09-30 | −$1.1m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2012-01-01 to 2012-09-30 | −$3.5m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2012-07-01 to 2012-09-30 | −$1.1m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2012-01-01 to 2012-09-30 | −$1.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2012-07-01 to 2012-09-30 | −$476.4k | us-gaap:NetIncomeLoss |
| Net income | 9 months2012-01-01 to 2012-09-30 | −$1.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2012-07-01 to 2012-09-30 | −$0.02 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 9 months2012-01-01 to 2012-09-30 | −$0.06 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted shares (weighted) | 3 months2012-07-01 to 2012-09-30 | 23,179,066 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2012-01-01 to 2012-09-30 | 23,179,066 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2012-01-01 to 2012-09-30 | −$2.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2012-01-01 to 2012-09-30 | $36.2k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2012-09-30 | $6.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2012-09-30 | $6.7m | us-gaap:AssetsCurrent |
| Total assets | At period end2012-09-30 | $14.7m | us-gaap:Assets |
| Current liabilities | At period end2012-09-30 | $1.5m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | At period end2012-09-30 | $13.2m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001144204-12-063883. Last ingested by Listed: Oct 24, 2026, 15:00 ET. Listed shows no prices and gives no investment advice.